 | • レポートコード：TPM-NV176 • 出版社/出版日：Transparency Market Research / 2019年10月28日 • レポート形態：英文、PDF、238ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、バイオバンキングの世界市場について調べ、バイオバンキングの世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別（機器、消耗品、およびソフトウェア＆サービス）分析、生体試料別（血液製剤、ヒト組織、細胞株、核酸、その他）分析、用途別（治療、臨床診断、創薬および開発、その他）分析、ストレージ別（手動および自動化）分析、関連企業情報などをまとめました。 ・バイオバンキングの市場概要 ・バイオバンキングの市場動向 ・バイオバンキングの世界市場規模・予測 ・バイオバンキング市場：製品別（機器、消耗品、およびソフトウェア＆サービス） ・バイオバンキング市場：生体試料別（血液製剤、ヒト組織、細胞株、核酸、その他） ・バイオバンキング市場：生体試料別（血液製剤、ヒト組織、細胞株、核酸、その他） ・バイオバンキング市場：ストレージ別（手動および自動化） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
The collected terabytes of biological data and its associated information are revolutionizing healthcare infrastructure across nations. Likewise, stakeholders in the biobanking market are increasing their focus on personalized medicines to meet the growing demand for the specific diagnosis for rare-case diseases. In 2017, North America topped the list of major countries in the world, and contributed ~17% of its GDP towards healthcare spending. Correspondingly, North America is projected to dominate market revenue throughout the forecast period in the biobanking market.
Healthcare companies are seeking result-oriented outcomes in personalized medicine space though the development of new drugs. This is being made possible with the help of high-quality biospecimens from biobanks. Thus, stakeholders in the biobanking market and healthcare companies are closely related, as the early detection and prevention of diseases is heavily dependent upon the data received by companies on specific biomarkers. Growing awareness about the types of cancer, cardiovascular diseases, and neurological disorders are paving the way for emanant development of a personalized medicine ecosystem.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Biobanking Market: Market Snapshot
4. Market Overview
4.1. Global Biobanking Market: Product Overview
4.2. Global Biobanking Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biobanking Market Revenue Projections, 2017–2027
4.5. Global Biobanking Market Outlook
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Healthcare Industry Overview
5.4. Regulatory Scenario by Region/globally
5.5. List of Major Biobanks, by Region
5.6. List of Vendors Supporting Automated Biobanking
6. Global Biobanking Market Analysis, by Product
6.1. Key Findings
6.2. Introduction
6.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Product
6.4. Global Biobanking Market Forecast, by Product
6.4.1. Equipment
6.4.1.1. Temperature Control Systems
6.4.1.1.1. Freezers & Refrigerators
6.4.1.1.2. Cryogenic Storage Systems
6.4.1.1.3. Thawing Equipment
6.4.1.1.4. Incubators & Centrifuges
6.4.1.2. Alarms & Monitoring Systems
6.4.1.3. Accessories & Other equipment
6.4.2. Consumables
6.4.2.1. Cryovials & Cryomolds
6.4.2.2. Tubes
6.4.2.3. Others
6.4.3. Software & Services
6.5. Global Biobanking Market Analysis, by Product, 2017–2027
7. Global Biobanking Market Analysis, by Biospecimen Type
7.1. Key Findings
7.2. Introduction
7.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
7.4. Global Biobanking Market Forecast, by Biospecimen Type
7.4.1. Blood Products
7.4.2. Human Tissues
7.4.3. Cell Lines
7.4.4. Nucleic Acids
7.4.5. Others
7.5. Global Biobanking Market Analysis, by Biospecimen Type, 2017–2027
8. Global Biobanking Market Analysis, by Application
8.1. Key Findings
8.2. Introduction
8.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Application
8.4. Global Biobanking Market Forecast, by Application
8.4.1. Therapeutics
8.4.2. Clinical Diagnostics
8.4.3. Drug Discovery & Development
8.4.4. Others
8.5. Global Biobanking Market Analysis, by Application, 2017–2027
9. Global Biobanking Market Analysis, by Storage Type
9.1. Key Findings
9.2. Introduction
9.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
9.4. Global Biobanking Market Forecast, by Storage Type
9.4.1. Manual
9.4.2. Automated
9.5. Global Biobanking Market Analysis, by Storage Type, 2017–2027
10. Global Biobanking Market Analysis, by Region
10.1. Global Biobanking Market Scenario, by Country
10.2. Global Biobanking Market Value Share and Attractiveness Analysis, by Region
10.3. Global Biobanking Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Biobanking Market Analysis
11.1. Key Findings
11.2. North America Biobanking Market Value Share and Attractiveness Analysis, by Country
11.3. North America Biobanking Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Biobanking Market Value Share and Attractiveness Analysis, by Product
11.5. North America Biobanking Market Forecast, by Product
11.5.1. Equipment
11.5.1.1. Temperature Control Systems
11.5.1.1.1. Freezers & Refrigerators
11.5.1.1.2. Cryogenic Storage Systems
11.5.1.1.3. Thawing Equipment
11.5.1.2. Incubators & Centrifuges
11.5.1.3. Alarms & Monitoring Systems
11.5.1.4. Accessories & Other equipment
11.5.2. Consumables
11.5.2.1. Cryovials & Cryomolds
11.5.2.2. Tubes
11.5.2.3. Others
11.5.3. Software & Services
11.6. North America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
11.7. North America Biobanking Market Forecast, by Biospecimen Type
11.7.1. Blood Products
11.7.2. Human Tissues
11.7.3. Cell Lines
11.7.4. Nucleic Acids
11.7.5. Others
11.8. North America Biobanking Market Value Share and Attractiveness Analysis, by Application
11.9. North America Biobanking Market Forecast, by Application
11.9.1. Therapeutics
11.9.2. Clinical Diagnostics
11.9.3. Drug Discovery & Development
11.9.4. Others
11.10. North America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
11.11. North America Biobanking Market Forecast, by Storage Type
11.11.1. Manual
11.11.2. Automated
12. Europe Biobanking Market Analysis
12.1. Key Findings
12.2. Europe Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Biobanking Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Biobanking Market Value Share and Attractiveness Analysis, by Product
12.5. Europe Biobanking Market Forecast, by Product
12.5.1. Equipment
12.5.1.1. Temperature Control Systems
12.5.1.1.1. Freezers & Refrigerators
12.5.1.1.2. Cryogenic Storage Systems
12.5.1.1.3. Thawing Equipment
12.5.1.2. Incubators & Centrifuges
12.5.1.3. Alarms & Monitoring Systems
12.5.1.4. Accessories & Other equipment
12.5.2. Consumables
12.5.2.1. Cryovials & Cryomolds
12.5.2.2. Tubes
12.5.2.3. Others
12.5.3. Software & Services
12.6. Europe Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
12.7. Europe Biobanking Market Forecast, by Biospecimen Type
12.7.1. Blood Products
12.7.2. Human Tissues
12.7.3. Cell Lines
12.7.4. Nucleic Acids
12.7.5. Others
12.8. Europe Biobanking Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Biobanking Market Forecast, by Application
12.9.1. Therapeutics
12.9.2. Clinical Diagnostics
12.9.3. Drug Discovery & Development
12.9.4. Others
12.10. Europe Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
12.11. Europe Biobanking Market Forecast, by Storage Type
12.11.1. Manual
12.11.2. Automated
13. Asia Pacific Biobanking Market Analysis
13.1. Key Findings
13.2. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Biobanking Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Product
13.5. Asia Pacific Biobanking Market Forecast, by Product
13.5.1. Equipment
13.5.1.1. Temperature Control Systems
13.5.1.1.1. Freezers & Refrigerators
13.5.1.1.2. Cryogenic Storage Systems
13.5.1.1.3. Thawing Equipment
13.5.1.2. Incubators & Centrifuges
13.5.1.3. Alarms & Monitoring Systems
13.5.1.4. Accessories & Other equipment
13.5.2. Consumables
13.5.2.1. Cryovials & Cryomolds
13.5.2.2. Tubes
13.5.2.3. Others
13.5.3. Software & Services
13.6. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
13.7. Asia Pacific Biobanking Market Forecast, by Biospecimen Type
13.7.1. Blood Products
13.7.2. Human Tissues
13.7.3. Cell Lines
13.7.4. Nucleic Acids
13.7.5. Others
13.8. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Biobanking Market Forecast, by Application
13.9.1. Therapeutics
13.9.2. Clinical Diagnostics
13.9.3. Drug Discovery & Development
13.9.4. Others
13.10. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
13.11. Asia Pacific Biobanking Market Forecast, by Storage Type
13.11.1. Manual
13.11.2. Automated
14. Latin America Biobanking Market Analysis
14.1. Key Findings
14.2. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Biobanking Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Product
14.5. Latin America Biobanking Market Forecast, by Product
14.5.1. Equipment
14.5.1.1. Temperature Control Systems
14.5.1.1.1. Freezers & Refrigerators
14.5.1.1.2. Cryogenic Storage Systems
14.5.1.1.3. Thawing Equipment
14.5.1.2. Incubators & Centrifuges
14.5.1.3. Alarms & Monitoring Systems
14.5.1.4. Accessories & Other equipment
14.5.2. Consumables
14.5.2.1. Cryovials & Cryomolds
14.5.2.2. Tubes
14.5.2.3. Others
14.5.3. Software & Services
14.6. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
14.7. Latin America Biobanking Market Forecast, by Biospecimen Type
14.7.1. Blood Products
14.7.2. Human Tissues
14.7.3. Cell Lines
14.7.4. Nucleic Acids
14.7.5. Others
14.8. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Biobanking Market Forecast, by Application
14.9.1. Therapeutics
14.9.2. Clinical Diagnostics
14.9.3. Drug Discovery & Development
14.9.4. Others
14.10. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
14.11. Latin America Biobanking Market Forecast, by Storage Type
14.11.1. Manual
14.11.2. Automated
15. Middle East & Africa Biobanking Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Biobanking Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Product
15.5. Middle East & Africa Biobanking Market Forecast, by Product
15.5.1. Equipment
15.5.1.1. Temperature Control Systems
15.5.1.1.1. Freezers & Refrigerators
15.5.1.1.2. Cryogenic Storage Systems
15.5.1.1.3. Thawing Equipment
15.5.1.2. Incubators & Centrifuges
15.5.1.3. Alarms & Monitoring Systems
15.5.1.4. Accessories & Other equipment
15.5.2. Consumables
15.5.2.1. Cryovials & Cryomolds
15.5.2.2. Tubes
15.5.2.3. Others
15.5.3. Software & Services
15.6. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type
15.7. Middle East & Africa Biobanking Market Forecast, by Biospecimen Type
15.7.1. Blood Products
15.7.2. Human Tissues
15.7.3. Cell Lines
15.7.4. Nucleic Acids
15.7.5. Others
15.8. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Biobanking Market Forecast, by Application
15.9.1. Therapeutics
15.9.2. Clinical Diagnostics
15.9.3. Drug Discovery & Development
15.9.4. Others
15.10. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Storage Type
15.11. Middle East & Africa Biobanking Market Forecast, by Storage Type
15.11.1. Manual
15.11.2. Automated
16. Competition Landscape
16.1. Company Profiles
16.1.1. Thermo Fisher Scientific, Inc.
16.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.1.2. Company Financials
16.1.1.3. Growth Strategies
16.1.1.4. SWOT Analysis
16.1.2. PHC Holdings Corporation (Panasonic Healthcare)
16.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.2.2. Growth Strategies
16.1.2.3. SWOT Analysis
16.1.3. Hamilton Company
16.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.3.2. Company Financials
16.1.3.3. Growth Strategies
16.1.3.4. SWOT Analysis
16.1.4. Chart Industries, Inc.
16.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.4.2. Company Financials
16.1.4.3. Growth Strategies
16.1.4.4. SWOT Analysis
16.1.5. VWR International, LLC. (Avantor, Inc.)
16.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.5.2. Growth Strategies
16.1.5.3. SWOT Analysis
16.1.6. QIAGEN N.V.
16.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.6.2. Company Financials
16.1.6.3. Growth Strategies
16.1.6.4. SWOT Analysis
16.1.7. Greiner AG
16.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.7.2. Company Financials
16.1.7.3. Growth Strategies
16.1.7.4. SWOT Analysis
16.1.8. Brooks Automation, Inc.
16.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.8.2. Company Financials
16.1.8.3. Growth Strategies
16.1.8.4. SWOT Analysis
16.1.9. Merck KGaA
16.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.9.2. Company Financials
16.1.9.3. Growth Strategies
16.1.9.4. SWOT Analysis
16.1.10. Tecan Trading AG
16.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.10.2. Company Financials
16.1.10.3. Growth Strategies
16.1.10.4. SWOT Analysis